DYADIC INTERNATIONAL INC Treasury Stock Acquired, Average Cost Per Share
DYADIC INTERNATIONAL INC (DYAI) reported Treasury Stock Acquired, Average Cost Per Share of $1.52 per share for the 36-month period ending 2018-12-31, per its 10-K filed 2020-03-30.
Discontinued › Income Statement › Earnings Per Share
us-gaap:TreasuryStockAcquiredAverageCostPerShare · last filed 2020-03-30
- DYADIC INTERNATIONAL INC treasury stock acquired, average cost per share for fiscal 2016 was $1.59.
| Period end | Treasury Stock Acquired, Average Cost Per Share | Treasury Stock Acquired, Average Cost Per Share 1 month | Treasury Stock Acquired, Average Cost Per Share 2 month | Treasury Stock Acquired, Average Cost Per Share 4 month | Treasury Stock Acquired, Average Cost Per Share 8 month | Treasury Stock Acquired, Average Cost Per Share 12 month | Treasury Stock Acquired, Average Cost Per Share 36 month |
|---|---|---|---|---|---|---|---|
| 2018-12-31 | $1.52 10-K · filed 2020-03-30 | ||||||
| 2018-08-31 | $1.40 10-K · filed 2019-03-27 | $1.40 10-K · filed 2020-03-30 | |||||
| 2018-03-31 | $1.41 10-K · filed 2019-03-27 | ||||||
| 2018-01-31 | $1.40 10-K · filed 2019-03-27 | ||||||
| 2017-12-31 | $1.41 10-K · filed 2020-03-30 | ||||||
| 2017-02-28 | $1.48 10-K · filed 2019-03-27 | $1.58 10-K · filed 2020-03-30 | |||||
| 2017-01-31 | $1.60 10-K · filed 2019-03-27 | ||||||
| 2017-01-11 | $1.54 10-K · filed 2020-03-30 | ||||||
| 2016-12-31 | $1.59 10-K · filed 2019-03-27 | ||||||
| 2016-01-12 | $1.35 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |